0013SP |
Acamprosate, Serum/Plasma |
0021B |
Acetaldehyde, Blood |
0021SP |
Acetaldehyde, Serum/Plasma |
0021U |
Acetaldehyde, Urine |
0080B |
Acetone, Blood |
0080FL |
Acetone, Fluid |
0080SP |
Acetone, Serum/Plasma |
0080U |
Acetone, Urine |
0088B |
Acetonitrile Exposure Profile, Blood |
0088U |
Acetonitrile Exposure Profile, Urine |
0100SP |
Acetophenazine, Serum/Plasma |
0148B |
Acrylonitrile Exposure Profile, Blood |
0148U |
Acrylonitrile Exposure Profile, Urine |
0190B |
Aldrin/Dieldrin, Blood |
0190SP |
Aldrin/Dieldrin, Serum/Plasma |
0213SP |
Allopurinol and Metabolite, Serum/Plasma |
0230B |
Alcohol with reflex to DUID Screen, Blood (Forensic) |
0264B |
Aluminum, Blood |
0264FL |
Aluminum, Fluid |
0264H |
Aluminum, Hair |
0264LI |
Aluminum, Liquid |
0264R |
Aluminum, RBCs |
0264SP |
Aluminum, Serum/Plasma |
0264TI |
Aluminum, Tissue |
0264U |
Aluminum, Urine |
0264UH |
Aluminum, 24 Hour Urine |
0275SP |
Dalfampridine, Serum/Plasma |
0275U |
Dalfampridine, Urine |
0307B |
Amiodarone and Metabolite, Blood |
0307SP |
Amiodarone and Metabolite, Serum/Plasma |
0329B |
Amphetamines (D/L Differentiation), Blood |
0329FL |
Amphetamines (D/L Differentiation), Fluid |
0329SP |
Amphetamines (D/L Differentiation), Serum/Plasma |
0329U |
Amphetamines (D/L Differentiation), Urine |
0337B |
Amphetamines Screen, Blood |
0337FL |
Amphetamines Screen, Fluid |
0337SP |
Amphetamines Screen, Serum/Plasma |
0337U |
Amphetamines Screen, Urine |
0406B |
Anticoagulant Poisoning Panel (Qualitative), Blood |
0406SP |
Anticoagulant Poisoning Panel (Qualitative), Serum/Plasma |
0406TI |
Anticoagulant Poisoning Panel (Qualitative), Tissue |
0410B |
Antimony, Blood |
0410H |
Antimony, Hair |
0410LI |
Antimony, Liquid |
0410N |
Antimony, Nails |
0410R |
Antimony, RBCs |
0410SP |
Antimony, Serum/Plasma |
0410U |
Antimony, Urine |
0451B |
Aripiprazole, Blood |
0451SP |
Aripiprazole, Serum/Plasma |
0460B |
Arsenic, Blood |
0460FL |
Arsenic, Fluid |
0460H |
Arsenic, Hair |
0460N |
Arsenic, Nails |
0460R |
Arsenic, RBCs |
0460SP |
Arsenic, Serum/Plasma |
0460TI |
Arsenic, Tissue |
0460U |
Arsenic, Urine |
0460UH |
Arsenic, 24 Hour Urine |
0468U |
Arsenic, Total Inorganic, Urine |
0468UH |
Arsenic, Total Inorganic, 24 Hour Urine |
0470UH |
Total, Inorganic Arsenic, 24 Hour Urine (+Creatinine) |
0474SP |
Asenapine, Serum/Plasma |
0519B |
Barium, Blood |
0519H |
Barium, Hair |
0519SP |
Barium, Serum/Plasma |
0519TI |
Barium, Tissue |
0519U |
Barium, Urine |
0541B |
Benzene, Blood |
0541TI |
Benzene, Tissue |
0542U |
Benzene Incident, Urine (OSHA) |
0543U |
Benzene OSHA Exposure Panel, Urine |
0556U |
Benzidine, Urine |
0560P |
Benzocaine, Plasma |
0560U |
Benzocaine, Urine |
0585B |
Benzonatate, Blood |
0585SP |
Benzonatate, Serum/Plasma |
0585U |
Benzonatate, Urine |
0620B |
Benztropine, Blood |
0620SP |
Benztropine, Serum/Plasma |
0620TI |
Benztropine, Tissue |
0620U |
Benztropine, Urine |
0638B |
Beryllium, Blood |
0638LI |
Beryllium, Liquid |
0638SP |
Beryllium, Serum/Plasma |
0638U |
Beryllium, Urine |
0641B |
Sotalol, Blood |
0641SP |
Sotalol, Serum/Plasma |
0649SP |
Methotrexate, Serum/Plasma |
0680B |
Bismuth, Blood |
0680SP |
Bismuth, Serum/Plasma |
0680U |
Bismuth, Urine |
0690SP |
Bisphenol A - Free (Unconjugated), Serum/Plasma |
0690U |
Bisphenol A - Total (Conjugated/Unconjugated), Urine |
0711B |
Boron, Blood |
0711SP |
Boron, Serum/Plasma |
0711U |
Boron, Urine |
0716SP |
Brexpiprazole, Serum/Plasma |
0718B |
Brivaracetam, Blood |
0718SP |
Brivaracetam, Serum/Plasma |
0720B |
Bromine - Total, Blood |
0720SP |
Bromine - Total, Serum/Plasma |
0720U |
Bromine - Total, Urine |
0770B |
Brompheniramine, Blood |
0770SP |
Brompheniramine, Serum/Plasma |
0770U |
Brompheniramine, Urine |
0785B |
Aromatic Solvents Exposure Panel, Blood |
0796B |
Bumetanide, Blood |
0796SP |
Bumetanide, Serum/Plasma |
0800B |
Bupivacaine, Blood |
0800FL |
Bupivacaine, Fluid |
0800SP |
Bupivacaine, Serum/Plasma |
0800U |
Bupivacaine, Urine |
0803B |
Bupropion and Metabolite, Blood |
0803FL |
Bupropion and Metabolite, Fluid |
0803SP |
Bupropion and Metabolite, Serum/Plasma |
0803TI |
Bupropion and Metabolite, Tissue |
0803U |
Bupropion and Metabolite, Urine |
0805B |
Buspirone, Blood |
0805SP |
Buspirone, Serum/Plasma |
0805U |
Buspirone, Urine |
0835B |
Butane and Isobutane, Blood |
0921B |
Cadmium, Blood |
0921H |
Cadmium, Hair |
0921N |
Cadmium, Nails |
0921R |
Cadmium, RBCs |
0921SP |
Cadmium, Serum/Plasma |
0921TI |
Cadmium, Tissue |
0921U |
Cadmium, Urine |
0921UH |
Cadmium, 24 Hour Urine |
0970B |
Carbamazepine and Metabolite, Blood |
0970FL |
Carbamazepine and Metabolite, Fluid |
0970SP |
Carbamazepine and Metabolite, Serum/Plasma |
0970TI |
Carbamazepine and Metabolite, Tissue |
0971SP |
Carbamazepine and Metabolite - Free, Serum/Plasma |
0972SP |
Carbamazepine and Metabolite - Total/Free/Bound, Serum/Plasma |
0975SP |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
0975U |
Carbamazepine-10,11-Epoxide, Urine |
0985B |
Carbinoxamine, Blood |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1000B |
Carboxy-, Met- and Sulf-Hemoglobin, Blood |
1002B |
Carbon Monoxide Exposure Biouptake Screen, Blood |
1005B |
Carbon Monoxide Profile, Blood |
1006B |
Carbon Monoxide - Iron Ratio Profile, Blood |
1006TI |
Carbon Monoxide - Iron Ratio Profile, Tissue |
1009B |
Carbon Monoxide Exposure, Blood |
1010B |
Carbon Tetrachloride, Blood |
1019B |
Carbrital Profile, Blood |
1019SP |
Carbrital Profile, Serum/Plasma |
1030B |
Carisoprodol and Metabolite, Blood |
1030FL |
Carisoprodol and Metabolite, Fluid |
1030SP |
Carisoprodol and Metabolite, Serum/Plasma |
1030U |
Carisoprodol and Metabolite, Urine |
1033ST |
Cathartic Laxatives Profile, Stool |
1038B |
Ethylene Glycol Monobutyl Ether, Blood |
1038SP |
Ethylene Glycol Monobutyl Ether, Serum/Plasma |
1039B |
Ethylene Glycol Monoethyl Ether, Blood |
1039SP |
Ethylene Glycol Monoethyl Ether, Serum/Plasma |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1042B |
Cesium, Blood |
1042SP |
Cesium, Serum/Plasma |
1042U |
Cesium, Urine |
1044B |
Chloral Hydrate, Blood |
1044SP |
Chloral Hydrate, Serum/Plasma |
1044U |
Chloral Hydrate, Urine |
1056B |
Cenobamate, Blood |
1056SP |
Cenobamate, Serum/Plasma |
1070B |
Chlordane and Metabolites, Blood |
1070SP |
Chlordane and Metabolites, Serum/Plasma |
1110B |
Chlorobenzene, Blood |
1110SP |
Chlorobenzene, Serum/Plasma |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1130B |
Chloroform, Blood |
1180B |
Chlorothiazide, Blood |
1180SP |
Chlorothiazide, Serum/Plasma |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1287B |
Clozapine and Metabolite, Blood |
1287FL |
Clozapine and Metabolite, Fluid |
1287SP |
Clozapine and Metabolite, Serum/Plasma |
1287TI |
Clozapine and Metabolite, Tissue |
1287U |
Clozapine and Metabolite, Urine |
1320B |
Colchicine, Blood |
1320SP |
Colchicine, Serum/Plasma |
1320TI |
Colchicine, Tissue |
1333SP |
Copper - Free, Serum/Plasma |
1348U |
Creatinine, Urine Overview: Evaluate Extent of Urine Dilution or Concentration |
1352U |
o-Cresol, Urine |
1355U |
o-Toluidine, Urine |
1380B |
Cyanide, Blood |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
1415B |
Cyclosporine, Blood |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
1439SP |
Dantrolene, Serum/Plasma |
1440B |
Dapsone and Metabolite, Blood |
1440SP |
Dapsone and Metabolite, Serum/Plasma |
1470B |
DDT, DDD and DDE, Blood |
1470F |
DDT, DDD and DDE, Fat |
1470SP |
DDT, DDD and DDE, Serum/Plasma |
1546B |
Dichlorobenzenes, Blood |
1546SP |
Dichlorobenzenes, Serum/Plasma |
1549U |
Dichlorobenzidine, Urine |
1550B |
Dichloroethane, Blood |
1560B |
Dichloromethane and Carboxyhemoglobin, Blood |
1561B |
Dichloromethane, Blood |
1561U |
Dichloromethane, Urine |
1567U |
Dichlorophenol 2,5-, Urine |
1575B |
Dicyclomine, Blood |
1575SP |
Dicyclomine, Serum/Plasma |
1575U |
Dicyclomine, Urine |
1589B |
Diethylene Glycol, Blood |
1589SP |
Diethylene Glycol, Serum/Plasma |
1589U |
Diethylene Glycol, Urine |
1590B |
Diethyl Ether, Blood |
1590SP |
Diethyl Ether, Serum/Plasma |
1611B |
Tetrafluoroethane and Difluoroethane Panel, Blood |
1690B |
Dimethylsulfoxide, Blood |
1690SP |
Dimethylsulfoxide, Serum/Plasma |
1690U |
Dimethylsulfoxide, Urine |
1740B |
Dioxane-1,4, Blood |
1740SP |
Dioxane-1,4, Serum/Plasma |
1760B |
Diphenhydramine, Blood |
1760FL |
Diphenhydramine, Fluid |
1760SP |
Diphenhydramine, Serum/Plasma |
1760TI |
Diphenhydramine, Tissue |
1760U |
Diphenhydramine, Urine |
1790SP |
Disulfiram (DEDTC Metabolite) (Qualitative), Serum/Plasma |
1804SP |
Diuretics Panel, Serum/Plasma |
1810B |
Doxepin and Metabolite, Blood |
1810FL |
Doxepin and Metabolite, Fluid |
1810SP |
Doxepin and Metabolite, Serum/Plasma |
1810U |
Doxepin and Metabolite, Urine |
1812B |
Donepezil, Blood |
1812FL |
Donepezil, Fluid |
1812SP |
Donepezil, Serum/Plasma |
1817B |
Doxylamine, Blood |
1817FL |
Doxylamine, Fluid |
1817SP |
Doxylamine, Serum/Plasma |
1817TI |
Doxylamine, Tissue |
1817U |
Doxylamine, Urine |
1828B |
Dronedarone, Blood |
1828SP |
Dronedarone, Serum/Plasma |
1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
1900B |
Dyazide, Blood |
1900SP |
Dyazide, Serum/Plasma |
1919FL |
Electrolytes and Glucose Panel (Vitreous), Fluid (Forensic) |
1920B |
Endrin, Blood |
1920SP |
Endrin, Serum/Plasma |
1923B |
Enflurane, Blood |
1968B |
Eszopiclone / Zopiclone, Blood |
1968SP |
Eszopiclone / Zopiclone, Serum/Plasma |
1968TI |
Eszopiclone / Zopiclone, Tissue |
1968U |
Eszopiclone / Zopiclone, Urine |
1970SP |
Ethchlorvynol, Serum/Plasma |
1970U |
Ethchlorvynol Overdose, Urine |
1980B |
Ethinamate, Blood |
1980SP |
Ethinamate, Serum/Plasma |
2000B |
Ethosuximide, Blood |
2000SP |
Ethosuximide, Serum/Plasma |
2000U |
Ethosuximide, Urine |
2010B |
Ethotoin, Blood |
2010SP |
Ethotoin, Serum/Plasma |
2029U |
Ethylbenzene Exposure Biouptake, Urine |
2030B |
Ethylbenzene, Blood |
2050B |
Methyl Tertiary Butyl Ether, Blood |
2051B |
Methyl Tertiary Butyl Ether and Metabolite, Blood |
2051U |
Methyl Tertiary Butyl Ether and Metabolite, Urine |
2055B |
Ethylene Glycol Overexposure Profile, Blood |
2055SP |
Ethylene Glycol Overexposure Profile, Serum/Plasma |
2062B |
Ethylene Glycol, Blood |
2062FL |
Ethylene Glycol, Fluid |
2062SP |
Ethylene Glycol, Serum/Plasma |
2062TI |
Ethylene Glycol, Tissue |
2062U |
Ethylene Glycol, Urine |
2063B |
Etomidate, Blood |
2063P |
Etomidate, Plasma |
2066B |
Everolimus, Blood |
2069B |
Felbamate, Blood |
2069SP |
Felbamate, Serum/Plasma |
2088B |
Flecainide, Blood |
2088SP |
Flecainide, Serum/Plasma |
2088U |
Flecainide, Urine |
2090LI |
Fluoride Preservative Determination, Liquid |
2100B |
Fluorocarbon 113, Blood |
2100TI |
Fluorocarbon 113, Tissue |
2110B |
Fluphenazine, Blood |
2111B |
Baclofen, Blood |
2111FL |
Baclofen, Fluid |
2111SP |
Baclofen, Serum/Plasma |
2111U |
Baclofen, Urine |
2115SP |
Fluphenazine, Serum/Plasma |
2136B |
Fosphenytoin as Metabolite, Blood |
2136SP |
Fosphenytoin as Metabolite, Serum/Plasma |
2148B |
Galantamine, Blood |
2148SP |
Galantamine, Serum/Plasma |
2150B |
Gallium, Blood |
2150SP |
Gallium, Serum/Plasma |
2150U |
Gallium, Urine |
2156SP |
Germanium, Serum/Plasma |
2156U |
Germanium, Urine |
2160B |
Glutethimide, Blood |
2160SP |
Glutethimide, Serum/Plasma |
2164FL |
Glucose (Vitreous), Fluid (Forensic) |
2165B |
Glycols Panel, Blood |
2165FL |
Glycols Panel, Fluid |
2165LI |
Glycols Panel, Liquid |
2165SP |
Glycols Panel, Serum/Plasma |
2165TI |
Glycols Panel, Tissue |
2165U |
Glycols Panel, Urine |
2171B |
Gold, Blood |
2171SP |
Gold, Serum/Plasma |
2171U |
Gold, Urine |
2185B |
Guaifenesin, Blood |
2185SP |
Guaifenesin, Serum/Plasma |
2185U |
Guaifenesin, Urine |
2187SP |
Ganaxolone, Serum/Plasma |
2212B |
Halocarbons Panel, Blood |
2220B |
Haloperidol, Blood |
2220SP |
Haloperidol, Serum/Plasma |
2220TI |
Haloperidol, Tissue |
2278B |
Herbicides Panel 2, Blood |
2278SP |
Herbicides Panel 2, Serum/Plasma |
2278U |
Herbicides Panel 2, Urine |
2283B |
Hexachlorobenzene, Blood |
2283SP |
Hexachlorobenzene, Serum/Plasma |
2291U |
Hexanol, 1 and 2-, Urine |
2292U |
n-Hexane Exposure Monitoring, Urine |
2321B |
Hydrocarbon and Oxygenated Volatiles Panel, Blood |
2321FL |
Hydrocarbon and Oxygenated Volatiles Panel, Fluid |
2321TI |
Hydrocarbon and Oxygenated Volatiles Panel, Tissue |
2321U |
Hydrocarbon and Oxygenated Volatiles Panel, Urine |
2358U |
1-Hydroxypyrene, Urine |
2365B |
Hydroxyzine and Metabolite, Blood |
2365FL |
Hydroxyzine and Metabolite, Fluid |
2365SP |
Hydroxyzine and Metabolite, Serum/Plasma |
2365U |
Hydroxyzine and Metabolite, Urine |
2369B |
Hyoscyamine, Blood |
2369SP |
Hyoscyamine, Serum/Plasma |
2369U |
Hyoscyamine, Urine |
2395B |
Iloperidone, Blood |
2395SP |
Iloperidone, Serum/Plasma |
2397SP |
Indapamide, Serum/Plasma |
2406B |
Indium, Blood |
2406R |
Indium, RBCs |
2406SP |
Indium, Serum/Plasma |
2406U |
Indium, Urine |
2411B |
Inhalants Panel, Solvents, Blood |
2411TI |
Inhalants Panel, Solvents, Tissue |
2412B |
Inhalants Panel, Alkane Gases, Blood |
2412TI |
Inhalants Panel, Alkane Gases, Tissue |
2414B |
Inhalants Panel, Halocarbons, Blood |
2414TI |
Inhalants Panel, Halocarbons, Tissue |
2415B |
Volatile and Halocarbon Intoxicants, Blood |
2416U |
Aromatic Solvents Metabolites Panel, Urine |
2421B |
Inhalants Panel, Anesthetics, Blood |
2423B |
Comprehensive Volatiles Panel, Blood |
2425B |
Ipecac Use Markers Screen, Blood |
2425FL |
Ipecac Use Markers Screen, Fluid |
2425SP |
Ipecac Use Markers Screen, Serum/Plasma |
2425U |
Ipecac Use Markers Screen, Urine |
2428U |
Iodine - Total, Urine |
2436SP |
Isobutanol, Serum/Plasma |
2437B |
Isoflurane, Blood |
2445B |
Isopropanol and Acetone, Blood |
2445SP |
Isopropanol and Acetone, Serum/Plasma |
2445U |
Isopropanol and Acetone, Urine |
2456SP |
Isotretinoin, Serum/Plasma |
2458SP |
Isotretinoin and Metabolite, Serum/Plasma |
2479B |
Ketamine and Metabolite, Blood |
2479FL |
Ketamine and Metabolite, Fluid |
2479SP |
Ketamine and Metabolite, Serum/Plasma |
2479TI |
Ketamine and Metabolite, Tissue |
2479U |
Ketamine and Metabolite, Urine |
2480SP |
Ketone Bodies Panel, Serum/Plasma |
2481B |
Ketone Panel, Blood |
2481FL |
Ketone Panel, Fluid |
2481U |
Ketone Panel, Urine |
2484B |
Lamotrigine, Blood |
2484SP |
Lamotrigine, Serum/Plasma |
2484U |
Lamotrigine, Urine |
2490B |
Lead and ZPP, Blood |
2492B |
Lead, Blood |
2492FL |
Lead, Fluid |
2492H |
Lead, Hair |
2492LI |
Lead, Liquid |
2492N |
Lead, Nails |
2492R |
Lead, RBCs |
2492SP |
Lead, Serum/Plasma |
2492TI |
Lead, Tissue |
2492U |
Lead, Urine |
2492UH |
Lead, 24 Hour Urine |
2499U |
Laxatives Panel (Qualitative), Urine |
2505B |
Levetiracetam, Blood |
2505SP |
Levetiracetam, Serum/Plasma |
2506B |
Dextrorphan / Levorphanol Screen, Blood |
2506SP |
Dextrorphan / Levorphanol Screen, Serum/Plasma |
2517B |
Levocetirizine, Blood |
2517SP |
Levocetirizine, Serum/Plasma |
2525B |
Loratadine and Metabolite, Blood |
2525SP |
Loratadine and Metabolite, Serum/Plasma |
2525U |
Loratadine and Metabolite, Urine |
2527B |
Lacosamide, Blood |
2527FL |
Lacosamide, Fluid |
2527SP |
Lacosamide, Serum/Plasma |
2527U |
Lacosamide, Urine |
2531B |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Blood |
2531SP |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Serum/Plasma |
2532B |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Blood |
2532SP |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Serum/Plasma |
2533B |
Loperamide and Metabolite, Blood |
2533SP |
Loperamide and Metabolite, Serum/Plasma |
2534B |
Lithium Exposure, Blood |
2534SP |
Lithium Exposure, Serum/Plasma |
2534U |
Lithium Exposure , Urine |
2538B |
Loxapine, Blood |
2538SP |
Loxapine, Serum/Plasma |
2538U |
Loxapine, Urine |
2540B |
LSD Trace Analysis, Blood |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541B |
LSD Screen, Blood |
2541SP |
LSD Screen, Serum/Plasma |
2541U |
LSD Screen, Urine |
2543B |
Lurasidone, Blood |
2543SP |
Lurasidone, Serum/Plasma |
2581B |
Memantine, Blood |
2581SP |
Memantine, Serum/Plasma |
2584B |
Methylenedioxyamphetamine, Blood |
2584SP |
Methylenedioxyamphetamine, Serum/Plasma |
2584U |
Methylenedioxyamphetamine, Urine |
2585B |
Methylenedioxymethamphetamine and Metabolite, Blood |
2585SP |
Methylenedioxymethamphetamine and Metabolite, Serum/Plasma |
2585U |
Methylenedioxymethamphetamine and Metabolite, Urine |
2605B |
Menthol, Blood |
2605SP |
Menthol, Serum/Plasma |
2640B |
Mepivacaine, Blood |
2640SP |
Mepivacaine, Serum/Plasma |
2650B |
Meprobamate, Blood |
2650SP |
Meprobamate, Serum/Plasma |
2650U |
Meprobamate, Urine |
2661B |
Metals/Metalloids Panel 1, Blood |
2661H |
Metals/Metalloids Panel 1, Hair |
2661N |
Metals/Metalloids Panel 1, Nails |
2661SP |
Metals/Metalloids Panel 1, Serum/Plasma |
2661U |
Metals/Metalloids Panel 1, Urine |
2662B |
Metals/Metalloids Panel 2, Blood |
2662H |
Metals/Metalloids Panel 2, Hair |
2662N |
Metals/Metalloids Panel 2, Nails |
2662SP |
Metals/Metalloids Panel 2, Serum/Plasma |
2662U |
Metals/Metalloids Panel 2, Urine |
2663B |
Metals/Metalloids Panel 3, Blood |
2663H |
Metals/Metalloids Panel 3, Hair |
2663N |
Metals/Metalloids Panel 3, Nails |
2663SP |
Metals/Metalloids Panel 3, Serum/Plasma |
2663U |
Metals/Metalloids Panel 3, Urine |
2664U |
Metals Panel 4 (Arsenic, Cadmium, Lead, Mercury), Urine |
2664UH |
Metals Panel 4 (Arsenic, Cadmium, Lead, Mercury), 24 Hour Urine |
2665B |
Mercaptopurine and Metabolites, Blood |
2670B |
Mercury, Blood |
2670FL |
Mercury, Fluid |
2670H |
Mercury, Hair |
2670LI |
Mercury, Liquid |
2670N |
Mercury, Nails |
2670R |
Mercury, RBCs |
2670SP |
Mercury, Serum/Plasma |
2670TI |
Mercury, Tissue |
2670U |
Mercury, Urine |
2670UH |
Mercury, 24 Hour Urine |
2679B |
Mescaline, Blood |
2679SP |
Mescaline, Serum/Plasma |
2679U |
Mescaline, Urine |
2680B |
Mescaline Screen, Blood |
2680SP |
Mescaline Screen, Serum/Plasma |
2680U |
Mescaline Screen, Urine |
2693B |
Metals/Metalloids Acute Poisoning Panel, Blood |
2693FL |
Metals/Metalloids Acute Poisoning Panel, Fluid |
2693H |
Metals/Metalloids Acute Poisoning Panel, Hair |
2693R |
Metals/Metalloids Acute Poisoning Panel, RBCs |
2693SP |
Metals/Metalloids Acute Poisoning Panel, Serum/Plasma |
2693TI |
Metals/Metalloids Acute Poisoning Panel, Tissue |
2693U |
Metals/Metalloids Acute Poisoning Panel, Urine |
2720B |
Metaxalone, Blood |
2720SP |
Metaxalone, Serum/Plasma |
2720U |
Metaxalone, Urine |
2740B |
Metformin, Blood |
2740FL |
Metformin, Fluid |
2740SP |
Metformin, Serum/Plasma |
2740U |
Metformin, Urine |
2810B |
Methamphetamine and Metabolite, Blood |
2810FL |
Methamphetamine and Metabolite, Fluid |
2810SP |
Methamphetamine and Metabolite, Serum/Plasma |
2810U |
Methamphetamine and Metabolite, Urine |
2835B |
Methanol, Blood |
2835FL |
Methanol, Fluid |
2835SP |
Methanol, Serum/Plasma |
2835U |
Methanol, Urine |
2836U |
Methanol Exposure Profile, Urine |
2837B |
Methanol Poisoning Profile, Blood |
2837SP |
Methanol Poisoning Profile, Serum/Plasma |
2849B |
Methaqualone, Blood |
2849SP |
Methaqualone, Serum/Plasma |
2849U |
Methaqualone, Urine |
2863SP |
Methazolamide, Serum/Plasma |
2887B |
Methemoglobin, Blood |
2892B |
Methimazole, Blood |
2892SP |
Methimazole, Serum/Plasma |
2900B |
Methocarbamol, Blood |
2900FL |
Methocarbamol, Fluid |
2900SP |
Methocarbamol, Serum/Plasma |
2915B |
Dextro/Levo Methorphan, Blood |
2915SP |
Dextro/Levo Methorphan, Serum/Plasma |
2915TI |
Dextro/Levo Methorphan, Tissue |
2915U |
Dextro / Levo Methorphan - Total, Urine |
2917U |
Dextromethorphan and Metabolite Ratio - Total, Urine |
2950B |
Methsuximide as Metabolite, Blood |
2950SP |
Methsuximide as Metabolite, Serum/Plasma |
2970B |
Methyl Bromide as Metabolite, Blood |
2970SP |
Methyl Bromide as Metabolite, Serum/Plasma |
2970U |
Methyl Bromide as Metabolite, Urine |
2980B |
Methyl n-Butyl Ketone, Blood |
2982B |
Methyl Isobutyl Ketone, Blood |
2982U |
Methyl Isobutyl Ketone, Urine |
2984U |
Methyl n-Butyl Ketone Exposure Monitoring, Urine |
2986U |
Methylenedianiline, Urine |
2990B |
Methyl Ethyl Ketone, Blood |
2990SP |
Methyl Ethyl Ketone, Serum/Plasma |
2990U |
Methyl Ethyl Ketone, Urine |
3005B |
Methylchloroform Exposure, Blood |
3005SP |
Methylchloroform Exposure, Serum/Plasma |
3006U |
Methylchloroform, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3048SP |
Metribuzin, Serum/Plasma |
3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3059B |
Mitotane, Blood |
3059SP |
Mitotane, Serum/Plasma |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3063B |
Mycophenolic Acid and Metabolite, Blood |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3066B |
Mineral Profile, Blood |
3066R |
Mineral Profile, RBCs |
3066SP |
Mineral Profile, Serum/Plasma |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3092SP |
Moricizine, Serum/Plasma |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3099U |
Phthalates Panel, Urine |
3111B |
Naloxone - Free (Unconjugated), Blood |
3111SP |
Naloxone - Free (Unconjugated), Serum/Plasma |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116B |
Naltrexone and Metabolite - Free (Unconjugated), Blood |
3116SP |
Naltrexone and Metabolite - Free (Unconjugated), Serum/Plasma |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3118B |
Nateglinide, Blood |
3118SP |
Nateglinide, Serum/Plasma |
3140B |
Nickel, Blood |
3140FL |
Nickel, Fluid |
3140H |
Nickel, Hair |
3140N |
Nickel, Nails |
3140R |
Nickel, RBCs |
3140SP |
Nickel, Serum/Plasma |
3140TI |
Nickel, Tissue |
3140U |
Nickel, Urine |
3145B |
Nefazodone, Blood |
3145SP |
Nefazodone, Serum/Plasma |
3145U |
Nefazodone, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3168B |
Nitazenes Panel, Blood |
3174B |
Nitrate/Nitrite (Qualitative), Blood (Forensic) |
3174SP |
Nitrate/Nitrite (Qualitative), Serum/Plasma |
3214B |
Nitrous Oxide, Blood |
3214TI |
Nitrous Oxide, Tissue |
3225SP |
Nuedexta®, Serum/Plasma |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3243B |
Organochlorine Pesticides, Blood |
3243F |
Organochlorine Pesticides, Fat |
3243SP |
Organochlorine Pesticides, Serum/Plasma |
3243TI |
Organochlorine Pesticides, Tissue |
3248B |
Orphenadrine, Blood |
3248SP |
Orphenadrine, Serum/Plasma |
3248U |
Orphenadrine, Urine |
3250SP |
Oxalate, Serum/Plasma |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3292B |
Palladium, Blood |
3292SP |
Palladium, Serum/Plasma |
3292U |
Palladium, Urine |
3300B |
Papaverine, Blood |
3300SP |
Papaverine, Serum/Plasma |
3310B |
Paraldehyde and Metabolite, Blood |
3310SP |
Paraldehyde and Metabolite, Serum/Plasma |
3310U |
Paraldehyde and Metabolite, Urine |
3320SP |
Paramethadione, Serum/Plasma |
3325B |
Paraquat, Blood |
3325SP |
Paraquat, Serum/Plasma |
3371SP |
PCB Panel, Congeners, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3432U |
Perchloroethylene Exposure, Urine |
3433SP |
Perampanel, Serum/Plasma |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3510B |
Phenacetin and Metabolite, Blood |
3510U |
Phenacetin and Metabolite, Urine |
3525B |
Phenazopyridine, Blood |
3525SP |
Phenazopyridine, Serum/Plasma |
3525U |
Phenazopyridine, Urine |
3532B |
Phencyclidine Screen, Blood |
3532FL |
Phencyclidine Screen, Fluid |
3532SP |
Phencyclidine Screen, Serum/Plasma |
3532U |
Phencyclidine Screen, Urine |
3560B |
Pheniramine, Blood |
3621B |
Phenol - Free and Total, Blood |
3621SP |
Phenol - Free and Total, Serum/Plasma |
3621U |
Phenol Exposure, Urine |
3623B |
Phenol, Free, Blood |
3623SP |
Phenol, Free, Serum/Plasma |
3624B |
Phenol, Total, Blood |
3690B |
Phentermine, Blood |
3690SP |
Phentermine, Serum/Plasma |
3690U |
Phentermine, Urine |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3740B |
Phenyltoloxamine, Blood |
3740SP |
Phenyltoloxamine, Serum/Plasma |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3779B |
Pioglitazone, Blood |
3779SP |
Pioglitazone, Serum/Plasma |
3780B |
Alpha-Pinene, Blood |
3783B |
Platinum, Blood |
3783FL |
Platinum, Fluid |
3783SP |
Platinum, Serum/Plasma |
3783U |
Platinum, Urine |
3901SP |
Primidone, Serum/Plasma |
3957B |
Procyclidine, Blood |
3957SP |
Procyclidine, Serum/Plasma |
3957U |
Procyclidine, Urine |
3970B |
Promethazine, Blood |
3970SP |
Promethazine, Serum/Plasma |
3970TI |
Promethazine, Tissue |
3970U |
Promethazine, Urine |
3974B |
Propane, Blood |
3974TI |
Propane, Tissue |
3975B |
Propanol, n-, Blood |
3975SP |
Propanol, n-, Serum/Plasma |
3975U |
Propanol, n-, Urine |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |
4003B |
Propylene Glycol, Blood |
4003SP |
Propylene Glycol, Serum/Plasma |
4003U |
Propylene Glycol, Urine |
4025SP |
Ezogabine and Metabolite, Serum/Plasma |
4029B |
Psilocybin as Psilocin (Qualitative), Blood |
4029SP |
Psilocybin as Psilocin (Qualitative), Serum/Plasma |
4029U |
Psilocybin as Psilocin (Qualitative), Urine |
4030B |
Pyridine, Blood |
4030SP |
Pyridine, Serum/Plasma |
4030U |
Pyridine, Urine |
4038B |
Pyridostigmine, Blood |
4038SP |
Pyridostigmine, Serum/Plasma |
4038U |
Pyridostigmine, Urine |
4051B |
Quetiapine, Blood |
4051FL |
Quetiapine, Fluid |
4051SP |
Quetiapine, Serum/Plasma |
4051TI |
Quetiapine, Tissue |
4051U |
Quetiapine, Urine |
4071B |
Quinidine, Blood |
4071SP |
Quinidine, Serum/Plasma |
4075B |
Quinine/Quinidine Differentiation, Blood |
4075SP |
Quinine/Quinidine Differentiation, Serum/Plasma |
4086B |
Ramelteon and Metabolite, Blood |
4086SP |
Ramelteon and Metabolite, Serum/Plasma |
4086U |
Ramelteon and Metabolite, Urine |
4101B |
Repaglinide, Blood |
4101SP |
Repaglinide, Serum/Plasma |
4102B |
Rosiglitazone, Blood |
4102SP |
Rosiglitazone, Serum/Plasma |
4105B |
Risperidone and Metabolite, Blood |
4105FL |
Risperidone and Metabolite, Fluid |
4105SP |
Risperidone and Metabolite, Serum/Plasma |
4105TI |
Risperidone and Metabolite, Tissue |
4105U |
Risperidone and Metabolite, Urine |
4113B |
Paliperidone, Blood |
4113SP |
Paliperidone, Serum/Plasma |
4113U |
Paliperidone, Urine |
4120B |
Ropivacaine, Blood |
4120SP |
Ropivacaine, Serum/Plasma |
4120U |
Ropivacaine, Urine |
4124B |
Rubidium, Blood |
4124R |
Rubidium, RBCs |
4124SP |
Rubidium, Serum/Plasma |
4124U |
Rubidium, Urine |
4125B |
Rufinamide, Blood |
4125SP |
Rufinamide, Serum/Plasma |
4127B |
Suboxone® - Free, Blood |
4127SP |
Suboxone® - Free, Serum/Plasma |
4127U |
Suboxone® - Total, Urine |
4137B |
Salicylate, Blood |
4137FL |
Salicylate, Fluid |
4137SP |
Salicylate, Serum/Plasma |
4137U |
Salicylate, Urine |
4160B |
Scopolamine, Blood |
4160SP |
Scopolamine, Serum/Plasma |
4160U |
Scopolamine, Urine |
4170B |
Secobarbital, Blood |
4170SP |
Secobarbital, Serum/Plasma |
4170U |
Secobarbital, Urine |
4180U |
Selenium, Urine |
4190B |
Silicon, Blood |
4190SP |
Silicon, Serum/Plasma |
4190U |
Silicon, Urine |
4193B |
Sirolimus, Blood |
4197B |
Sildenafil and Metabolite, Blood |
4197SP |
Sildenafil and Metabolite, Serum/Plasma |
4197U |
Sildenafil and Metabolite, Urine |
4200B |
Silver, Blood |
4200SP |
Silver, Serum/Plasma |
4200U |
Silver, Urine |
4205SP |
Sinemet®, Serum/Plasma |
4207B |
Canrenone (Spironolactone metabolite), Blood |
4207SP |
Canrenone (Spironolactone metabolite), Serum/Plasma |
4211B |
Stiripentol, Blood |
4211SP |
Stiripentol, Serum/Plasma |
4212B |
Strontium, Blood |
4212SP |
Strontium, Serum/Plasma |
4212U |
Strontium, Urine |
4213U |
Styrene Exposure Profile, Urine |
4215B |
Strychnine, Blood |
4215FL |
Strychnine, Fluid |
4215SP |
Strychnine, Serum/Plasma |
4215TI |
Strychnine, Tissue |
4215U |
Strychnine, Urine |
4232B |
Styrene, Blood |
4232SP |
Styrene, Serum/Plasma |
4235B |
Sulfhemoglobin, Blood |
4235R |
Sulfhemoglobin, RBCs |
4236B |
Suvorexant, Blood |
4236SP |
Suvorexant, Serum/Plasma |
4239SP |
Sulfide Exposure Biouptake Marker, Serum/Plasma |
4261B |
Hypoglycemic Panel, Blood |
4261SP |
Hypoglycemic Panel, Serum/Plasma |
4275B |
Sumatriptan, Blood |
4275SP |
Sumatriptan, Serum/Plasma |
4275U |
Sumatriptan, Urine |
4297B |
Tadalafil, Blood |
4297SP |
Tadalafil, Serum/Plasma |
4305B |
Tacrine, Blood |
4305SP |
Tacrine, Serum/Plasma |
4306B |
Tacrolimus, Blood |
4311B |
Tamoxifen and Metabolites, Blood |
4311SP |
Tamoxifen and Metabolites, Serum/Plasma |
4320B |
Tellurium, Blood |
4320SP |
Tellurium, Serum/Plasma |
4320U |
Tellurium, Urine |
4327B |
Terpineol, Blood |
4355B |
Tetrahydrofuran, Blood |
4355SP |
Tetrahydrofuran, Serum/Plasma |
4355U |
Tetrahydrofuran, Urine |
4366B |
Teriflunomide (Therapeutic Drug Monitoring), Blood |
4366SP |
Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma |
4367B |
Teriflunomide (Pre-Pregnancy Monitoring), Blood |
4367SP |
Teriflunomide (Pre-Pregnancy Monitoring), Serum/Plasma |
4370B |
Thallium, Blood |
4370H |
Thallium, Hair |
4370LI |
Thallium, Liquid |
4370N |
Thallium, Nails |
4370SP |
Thallium, Serum/Plasma |
4370U |
Thallium, Urine |
4387B |
Theophylline, Blood |
4387SP |
Theophylline, Serum/Plasma |
4387U |
Theophylline, Urine |
4469B |
Thiothixene (Cis Isomer), Blood |
4469SP |
Thiothixene (Cis Isomer), Serum/Plasma |
4469U |
Thiothixene (Cis Isomer), Urine |
4472B |
Thiosulfate, Blood |
4472SP |
Thiosulfate, Serum/Plasma |
4472U |
Thiosulfate, Urine |
4478SP |
Thorium, Serum/Plasma |
4478U |
Thorium, Urine |
4479B |
Tiagabine, Blood |
4479SP |
Tiagabine, Serum/Plasma |
4485B |
Tin - Total, Blood |
4485H |
Tin - Total, Hair |
4485SP |
Tin - Total, Serum/Plasma |
4485U |
Tin - Total, Urine |
4486B |
Titanium, Blood |
4486FL |
Titanium, Fluid |
4486SP |
Titanium, Serum/Plasma |
4486U |
Titanium, Urine |
4487B |
Tizanidine, Blood |
4487SP |
Tizanidine, Serum/Plasma |
4489B |
Tofacitinib, Blood |
4489SP |
Tofacitinib, Serum/Plasma |
4510B |
Toluene, Blood |
4513U |
Toluene Exposure, Urine |
4519B |
Topiramate, Blood |
4519FL |
Topiramate, Fluid |
4519SP |
Topiramate, Serum/Plasma |
4519U |
Topiramate, Urine |
4525B |
Torsemide, Blood |
4525SP |
Torsemide, Serum/Plasma |
4535B |
Trazodone and mCPP, Blood |
4535FL |
Trazodone, Fluid |
4535SP |
Trazodone and mCPP, Serum/Plasma |
4535TI |
Trazodone, Tissue |
4535U |
Trazodone and mCPP, Urine |
4624B |
Trichloroacetic Acid, Blood |
4624SP |
Trichloroacetic Acid, Serum/Plasma |
4624U |
Trichloroacetic Acid, Urine |
4630B |
Methyl Chloroform, Blood |
4650B |
Trichloroethylene, Blood |
4650SP |
Trichloroethylene, Serum/Plasma |
4655B |
Antidepressants Panel 1, Blood |
4655FL |
Antidepressants Panel 1, Fluid |
4655SP |
Antidepressants Panel 1, Serum/Plasma |
4655TI |
Antidepressants Panel 1, Tissue |
4658U |
Trichloroethylene Exposure, Urine |
4660B |
Trifluoperazine, Blood |
4660SP |
Trifluoperazine, Serum/Plasma |
4700B |
Trimethadione and Metabolite, Blood |
4700SP |
Trimethadione and Metabolite, Serum/Plasma |
4700U |
Trimethadione and Metabolite, Urine |
4720B |
Triprolidine, Blood |
4720SP |
Triprolidine, Serum/Plasma |
4730B |
Tungsten, Blood |
4730SP |
Tungsten, Serum/Plasma |
4730U |
Tungsten, Urine |
4755U |
Uranium, Urine |
4755UH |
Uranium, 24 Hour Urine |
4757B |
Valproic Acid, Blood |
4757FL |
Valproic Acid, Fluid |
4757SP |
Valproic Acid, Serum/Plasma |
4757TI |
Valproic Acid, Tissue |
4757U |
Valproic Acid, Urine |
4759SP |
Valproic Acid - Unbound and Total, Serum/Plasma |
4761SP |
Valproic Acid, Unbound, Serum/Plasma |
4764B |
Vardenafil and Metabolite, Blood |
4764SP |
Vardenafil and Metabolite, Serum/Plasma |
4765B |
Vanadium, Blood |
4765R |
Vanadium, RBCs |
4765SP |
Vanadium, Serum/Plasma |
4765U |
Vanadium, Urine |
4774SP |
Vigabatrin, Serum/Plasma |
4778U |
Vinyl Chloride Metabolite, Urine |
4780SP |
Vitamin B3 (Niacin and Metabolites), Serum/Plasma |
4783B |
Voclosporin, Blood |
4791SP |
Vortioxetine, Serum/Plasma |
4815B |
Xylazine, Blood |
4815SP |
Xylazine, Serum/Plasma |
4815TI |
Xylazine, Tissue |
4815U |
Xylazine, Urine |
4820B |
Xylenes Panel, Blood |
4821U |
Xylene Exposure Panel, Urine |
4860B |
Ziprasidone, Blood |
4860SP |
Ziprasidone, Serum/Plasma |
4870SP |
Zirconium, Serum/Plasma |
4884SP |
Zonisamide, Serum/Plasma |
6303B |
Firefighter Core Baseline Profile, Blood |
6303U |
Firefighter Core Baseline Profile, Urine |
6317U |
Semi Conductor Panel, Urine |
6364R |
Inorganic Panel 64, RBCs |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6924H |
Amphetamines Screen, Hair |
6925H |
Phencyclidine Screen, Hair |
6943H |
Drugs of Abuse Screen (6 Panel), Hair |
6945H |
Therapeutic and Drugs of Abuse Screen, Hair |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
7542SP |
Ethanol - Title 17, Serum/Plasma - Send Out Overview: This test is orderable by California clients only; Forensic Analysis (Send-Out Test); DUI |
7542U |
Ethanol - Title 17, Urine - Send Out Overview: This test is orderable by California clients only; Forensic Analysis (Send-Out Test); DUI |
8001B |
Salicylates Screen, Blood |
8001FL |
Salicylates Screen, Fluid |
8001SP |
Salicylates Screen, Serum/Plasma |
8001TI |
Salicylates Screen, Tissue |
8001U |
Salicylates Screen, Urine |
8031U |
Child Drug Exposure Screen, Urine |
8044B |
Postmortem, TotalTox™ w/Vitreous Alcohol, Blood (Forensic) |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8052B |
Postmortem, Expanded, Blood (Forensic) |
8052FL |
Postmortem, Expanded, Fluid (Forensic) |
8052SP |
Postmortem, Expanded, Serum/Plasma (Forensic) |
8052TI |
Postmortem, Expanded, Tissue (Forensic) |
8052U |
Postmortem, Expanded, Urine (Forensic) |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8062B |
Postmortem, Expanded w/o Alcohol, Blood (Forensic) |
8062FL |
Postmortem, Expanded w/o Alcohol, Fluid (Forensic) |
8062TI |
Postmortem, Expanded w/o Alcohol, Tissue (Forensic) |
8062U |
Postmortem, Expanded w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8088B |
Qsymia®, Blood |
8088SP |
Qsymia®, Serum/Plasma |
8091B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
8091FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
8091SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8091TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
8091U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8092B |
Postmortem, Prescription Drugs Screen, Blood (Forensic) |
8092FL |
Postmortem, Prescription Drugs Screen, Fluid (Forensic) |
8092SP |
Postmortem, Prescription Drugs Screen, Serum/Plasma (Forensic) |
8092TI |
Postmortem, Prescription Drugs Screen, Tissue (Forensic) |
8092U |
Postmortem, Prescription Drugs Screen, Urine (Forensic) |
8096B |
Drugs of Abuse Screen (10 Panel), Blood |
8096SP |
Drugs of Abuse Screen (10 Panel), Serum/Plasma |
8096U |
Drugs of Abuse Screen (11 Panel), Urine |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8101B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
8101FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
8101SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8103B |
Environmental Exposure Screen, Blood |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8130B |
Postmortem, TotalTox™ w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8133B |
Postmortem, TotalTox™ w/6-MAM Confirmation, Blood (Forensic) |
8135B |
Postmortem, Expanded w/6-MAM Confirmation, Blood (Forensic) |
8136B |
Postmortem, Basic w/6-MAM Confirmation, Blood (Forensic) |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8600B |
Amphetamines Panel, Blood |
8600FL |
Amphetamines Panel, Fluid |
8600ME |
Amphetamines Panel (Qualitative), Meconium |
8600SP |
Amphetamines Panel, Serum/Plasma |
8600TI |
Amphetamines Panel, Tissue |
8600U |
Amphetamines Panel, Urine |
8700B |
Antidepressants Panel, Blood |
8700SP |
Antidepressants Panel, Serum/Plasma |
8700U |
Antidepressants Panel, Urine |
8705B |
Doxepin and Metabolite, Blood |
8705U |
Doxepin and Metabolite, Urine |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
8758B |
Hallucinogens Screen, Blood |
8758SP |
Hallucinogens Screen, Serum/Plasma |
8758U |
Hallucinogens Screen, Urine |
8761B |
Phencyclidine, Blood |
8761FL |
Phencyclidine, Fluid |
8761ME |
Phencyclidine (Qualitative), Meconium |
8761SP |
Phencyclidine, Serum/Plasma |
8761TI |
Phencyclidine, Tissue |
8761U |
Phencyclidine, Urine |
8890OF |
Amphetamines Panel (Qualitative), Oral Fluid (Saliva) |
8896OF |
Phencyclidine and Dextromethorphan (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9065B |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Blood |
9065SP |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Serum/Plasma |
9065TI |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Tissue |
9065U |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Urine |
9118B |
Brompheniramine Screen, Blood |
9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9159B |
Disopyramide Screen, Blood |
9159SP |
Disopyramide Screen, Serum/Plasma |
9163B |
Doxylamine Screen, Blood |
9163SP |
Doxylamine Screen, Serum/Plasma |
9171B |
Ethosuximide Screen, Blood |
9171SP |
Ethosuximide Screen, Serum/Plasma |
9171U |
Ethosuximide Screen, Urine |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9188B |
Ketamine and Metabolite Screen, Blood |
9188SP |
Ketamine and Metabolite Screen, Serum/Plasma |
9188U |
Ketamine and Metabolite Screen, Urine |
9190B |
Ketoacidosis Screen, Postmortem, Blood (Forensic) |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9200SP |
Mepivacaine Screen, Serum/Plasma |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9211B |
Mexiletine Screen, Blood |
9211SP |
Mexiletine Screen, Serum/Plasma |
9219B |
Orphenadrine Screen, Blood |
9222B |
Papaverine Screen, Blood |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9276B |
Thiothixene (Cis Isomer) Screen, Blood |
9276SP |
Thiothixene (Cis Isomer) Screen, Serum/Plasma |
9276U |
Thiothixene (Cis Isomer) Screen, Urine |
9293B |
Methylenedioxymethamphetamine and Metabolite Screen, Blood |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9306U |
Anabolic Steroids Screen, Urine |
9318U |
Diuretics Screen, Urine |
9326B |
Gamma-Hydroxybutyric Acid Screen, Blood |
9326FL |
Gamma-Hydroxybutyric Acid Screen, Fluid |
9326SP |
Gamma-Hydroxybutyric Acid Screen, Serum/Plasma |
9326U |
Gamma-Hydroxybutyric Acid Screen, Urine |
9327B |
Propane, Blood |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9401B |
Chloral Hydrate Screen, Blood |
9401SP |
Chloral Hydrate Screen, Serum/Plasma |
9401U |
Chloral Hydrate Screen, Urine |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |
9431B |
Antidepressants Screen, Blood |
9431SP |
Antidepressants Screen, Serum/Plasma |
9431U |
Antidepressants Screen, Urine |
9435B |
Doxepin and Metabolite Screen, Blood |
9435U |
Doxepin and Metabolite Screen, Urine |
9443B |
Glutethimide Screen, Blood |
9443SP |
Glutethimide Screen, Serum/Plasma |
9522B |
Methamphetamine and Amphetamine Screen, Blood |
9522SP |
Methamphetamine and Amphetamine Screen, Serum/Plasma |
9522U |
Methamphetamine and Amphetamine Screen, Urine |
CRIM_22000 |
22000 Controlled Substances - GC/MS Scan and Color Overview: Criminal/Independent Investigation
Crime Lab tests performed at NMS Labs include analysis of controlled substances, pharmaceutical preparations and unknown substances. |